Search

Your search keyword '"Leishmaniasis, Mucocutaneous pathology"' showing total 237 results

Search Constraints

Start Over You searched for: Descriptor "Leishmaniasis, Mucocutaneous pathology" Remove constraint Descriptor: "Leishmaniasis, Mucocutaneous pathology"
237 results on '"Leishmaniasis, Mucocutaneous pathology"'

Search Results

1. Oral Leishmaniasis in HIV-Positive and HIV-Negative Patients: A Comparative Analysis with Two New Case Reports.

2. Fever with perinasal and tongue lesions: A diagnostic challenge.

3. Leishmania RNA virus-1 is similarly detected among metastatic and non-metastatic phenotypes in a prospective cohort of American Tegumentary Leishmaniasis.

4. Tongue Nodule as Primary Manifestation of American Cutaneous Leishmaniasis in an Immunocompetent Patient.

5. Case Report: A Single-Center Case Series on Skin Manifestations of Leishmaniasis from a Non-Endemic State in Southern India.

6. Successful treatment with photodynamic therapy in a patient with nasal mucocutaneous leishmaniasis undergoing treatment with TNFα inhibitor.

7. Case Report: Unusual Presentation of Pharyngeal Mucosal Leishmaniasis due to Leishmania ( Viannia ) braziliensis .

8. Case Report: Mucosal Leishmaniasis in New York City.

9. Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital.

10. Leishmania Viannia guyanensis.

11. Case Report: Mucocutaneous Leishmaniasis Masquerading as Idiopathic Midline Granulomatous Disease.

12. First Molecular Report of Leishmania ( Leishmania ) amazonensis and Leishmania ( Viannia ) guyanensis in Paraguayan Inhabitants Using High-Resolution Melt-PCR.

13. Mucosal leishmaniasis: A forgotten disease, description and identification of species in 50 Colombian cases

14. Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent.

16. Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis.

17. [Atypical mycocutaneous manifestation of Leishmania tropica in a refugee].

18. A patient with chronic labial oedema and nodular palatal lesions.

19. Histopathological characteristics of cutaneous lesions caused by Leishmania Viannia panamensis in Panama.

20. Leprosy and American cutaneous leishmaniasis coinfection.

21. Mucosal leishmaniasis mimicking T-cell lymphoma in a patient receiving monoclonal antibody against TNFα.

22. Deforming Mucocutaneous Leishmaniasis of the Nose.

23. Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.

24. Cutaneous and visceral leishmaniasis during anti-TNFα therapy.

25. Local Delivery of the Toll-Like Receptor 9 Ligand CpG Downregulates Host Immune and Inflammatory Responses, Ameliorating Established Leishmania (Viannia) panamensis Chronic Infection.

26. Leishmaniasis recidivans in Ethiopia: cutaneous and mucocutaneous features.

27. Mucocutaneous leishmaniasis.

28. Mammalian Innate Immune Response to a Leishmania-Resident RNA Virus Increases Macrophage Survival to Promote Parasite Persistence.

29. Localized mucosal leishmaniasis caused by Leishmania infantum mimicking cancer in the rhinolaryngeal region.

30. American tegumentary leishmaniasis: T-cell differentiation profile of cutaneous and mucosal forms-co-infection with Trypanosoma cruzi.

31. Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management.

32. Further Evidence of an Association between the Presence of Leishmania RNA Virus 1 and the Mucosal Manifestations in Tegumentary Leishmaniasis Patients.

33. Differential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient.

34. Mucocutaneous leishmaniasis in an 11-year-old girl with ataxia telangectasia - case report.

35. Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients.

36. Mucosal leishmaniasis with primary oral involvement: a case series and a review of the literature.

37. Salivary gland homogenates from wild-caught sand flies Lutzomyia flaviscutellata and Lutzomyia (Psychodopygus) complexus showed inhibitory effects on Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis infection in BALB/c mice.

38. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

39. A case of mucocutaneous leishmaniasis diagnosed by serology.

40. Facial structure alterations and abnormalities of the paranasal sinuses on multidetector computed tomography scans of patients with treated mucosal leishmaniasis.

41. A multidisciplinary approach to an uncommon case of laryngeal leishmaniasis in Turkey.

42. MyD88 and TLR9 dependent immune responses mediate resistance to Leishmania guyanensis infections, irrespective of Leishmania RNA virus burden.

43. A prolonged incubation period in zosteriform Leishmania panamensis.

44. [Leishmaniasis].

45. Body weight as a determinant of clinical evolution in hamsters (Mesocricetus auratus) infected with Leishmania (Viannia) panamensis.

46. Three Leishmania/L. species--L. infantum, L. major, L. tropica--as causative agents of mucosal leishmaniasis in Iran.

47. Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002-2011: a case series.

48. First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran.

49. Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil.

50. Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection.

Catalog

Books, media, physical & digital resources